Commentary|Videos|July 11, 2025
Counseling Patients With Psoriasis on Roflumilast and Nonsteroidal Topicals
Author(s)Mona Shahriari, MD, FAAD, David Hartigan
Fact checked by: Victoria Johnson
In this video, the fourth in a 6-part series, panelists discuss recent advancements in PsO management.
Advertisement
Advertisement
In this HCPLive RX Review Special Report, Mona Shahriari, MD, Associate Clinical Professor of Dermatology at Yale University, sits down with David Hartigan, a biologic coordinator with Biologic Coordinators of Dermatology, to discuss patient counseling strategies and the importance of empathy when introducing new therapies such as topical roflumilast.
Advertisement
Advertisement
